Amsterdam-based Royal Philips released its earnings results for the second quarter of 2018 on July 23.
Here are four things to know about the company's performance:
1. Philips reported its sales remained constant at €4.3 billion (an estimated $5 billion) for the second quarter, compared to a similar estimated €4.3 billion in sales during the same period last year.
2. The company posted €1.8 billion (an estimated $2.1 billion) in sales for its diagnosis and treatment business segment, up 5 percent from the second quarter of 2017. The segment reported strong growth in the company's image-guided therapy and ultrasound solutions.
3. Philips reported €743 million (an estimated $866.6 million) in sales for its connected care and health informatics business segment, down 3 percent from the same period last year. The segment saw growth from its healthcare informatics solutions, along with its monitoring and analytics tools.
4. The company posted a net income from continuing operations of €186 million (an estimated $216.9 million) during the second quarter, up 15 percent from €161 million (an estimated $187.8 million) one year prior.